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Summary
All aging individuals will develop some degree of decline in
cognitive capacity as time progresses. The molecular and cellular
mechanisms leading to age-related cognitive decline are still not
fully understood. Through our previous research, we discovered
that active neural progenitor cells selectively become more
quiescent in response to aging, thus leading to the decline of
neurogenesis in the aged hippocampus. Here, we further find
that aging impaired dendrite development of newborn neurons.
Currently, no effective approach is available to increase neuro-
genesis or promote dendrite development of newborn neurons in
the aging brain. We found that systemically administration of 7,
8-dihydroxyflavone (DHF), a small molecule imitating brain-
derived neurotrophic factor (BDNF), significantly enhanced den-
drite length in the newborn neurons, while it did not promote
survival of immature neurons, in the hippocampus of 12-month-
old mice. DHF-promoted dendrite development of newborn
neurons in the hippocampus may enhance their function in the
aging animal leading to a possible improvement in cognition.
Key words: aging; brain-derived neurotrophic factor signal-
ing; dendritic morphology.
Introduction
Aging is a process in which overall body functions fall over time. As we
grow older, we can experience memory loss and cognitive decline,
including processing speed decrease, working memory deficits and
episodic memory encoding dysfunctions, which can interfere with our
daily routines (Hedden & Gabrieli, 2004). According to statistics from U.S.
CensusBureau, by 2050, theolder population,which is over 65-year-old, is
estimated to reach 83.7 million, accounting for around 20% of the total
population (Ortman et al., 2014). A treatment approach is urgently
needed to target aging-related cognition disorders. However, the molec-
ular and cellular mechanisms of age-dependent cognitive decline remain
elusive, impeding the development of an effective clinical treatment.
Hippocampal neurogenesis and synaptic plasticity, which are involved
in cognitive functions, are both greatly affected by the aging process
(Rao et al., 2006). Neurogenesis comprises several critical steps,
including neural stem/progenitor cell (NSC) proliferation, immature
neuron survival, dendrite development, maturation, and functional
integration (Ming & Song, 2005). Our previous study proved that aging
specifically reduces proliferation of active neural progenitors (Romine
et al., 2015). Additionally, the consistently low survival rate of newborn
neurons further impedes the production of newborn neurons that can
successfully integrate into existing neuronal circuitry in the aging animals
(Bondolfi et al., 2004; Rao et al., 2005).
After new neurons were generated in the hippocampus, morpho-
logical development and synaptic integration are required for appropri-
ate function. The morphological maturation serves as a foundation for
granule neurons to properly relay signal inputs received by dendritic
spines to the CA3 region by means of axons. In the adult hippocampal
dentate gyrus, newborn neurons generally grow proper axonal and
dendritic morphology and spine structure in around 3–4 weeks of birth,
while further structural modification lasts for months (Zhao et al., 2006).
Here, we found that aging, besides compromising neurogenesis,
significantly impairs dendrite development through diminishing dendritic
branches and total dendrite length. As dendrites provide a large surface
for synapse formation, reduction in dendritic branches and total dendrite
length ultimately damages synaptogenesis. So far, no effective approach
is available to prevent or rescue neurogenesis and dendrite development
from impairments during aging.
Both neurogenesis and morphological maturation of adult-born
neurons are known to be regulated by brain-derived neurotrophic factor
(BDNF), which functions through binding and activation of its specific
receptor, tropomyosin-related kinase receptor B (TrkB) (Tolwani et al.,
2002; Binder & Scharfman, 2004). The downstream effects of BDNF
promote neuronal growth, survival, migration and synapse modulation
(Alderson et al., 1990; Horch & Katz, 2002; Gorski et al., 2003; Cohen-
Cory et al., 2010). In particular, BDNF plays an important role in
regulating dendrite development and later functional and structural
synaptic plasticity in the hippocampus (Tolwani et al., 2002; Vigers
et al., 2012; Wang et al., 2015) and, thus, is functionally involved in
memory formation and consolidation (Vigers et al., 2012). However, the
BDNF-TrkB system is particularly sensitive to the effects of aging, which
may help explain the age-related decline in hippocampal-dependent
memory (Calabrese et al., 2013; Budni et al., 2015) and provide a
therapeutic target for improving memory function in the aging popu-
lation. Although BDNF is a vital neurotrophic factor, its limited delivery,
short half-life and inability to cross the blood–brain barrier hinder its
effectiveness as a therapeutic agent. Alternatively, 7,8-dihydroxyflavone
(DHF), a small molecule that can mimic BDNF to activate TrkB receptors
(Jang et al., 2010), is advantageous, because it can cross the blood–
brain barrier, is unlikely to cause an immune response, and can be
noninvasively administered via intramuscular (i.m.), intraperitoneal (i.p.),
or intravenous (i.v.) injections.
Our previous studies proved that DHF, as a highly potent BDNF
receptor agonist, can promote neurogenesis and dendrite development
in the hippocampus of adult mice in the case of traumatic brain injury
(Zhao et al., 2015), indicating the beneficial effects of DHF. In this study,
we sought to determine whether DHF benefits aged mice by promoting
newborn neuron survival and their dendrite development in the
hippocampus.
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Results
Aging dramatically reduces the number of newborn
immature neuron and impairs dendritic morphology in the
hippocampus
Cognitive decline is a hallmark of the aging process, while the
mechanism remains elusive (Bishop et al., 2010). Among the potential
mechanisms, decreased neuroplasticity in the hippocampus represented
by neurogenesis reduction and synapses loss is an important contributor
(Burke & Barnes, 2006). Neurogenesis, including NSC proliferation,
immature neuron survival, migration, maturation, dendritic develop-
ment, and functional integration (Ming & Song, 2005), is affected by
aging at several levels. Our previous study demonstrated that aging
impairs neurogenesis largely by compromising NSC, especially active
neural progenitors, proliferation in the hippocampus in mice (Romine
et al., 2015). Here, we further assessed the number of newborn
immature neurons and their dendrite development in the 3-month-old
(n = 3) and 12-month-old (n = 4) mice. Series of every sixth brain
sections were processed for immunostaining with antibody against
doublecortin (Dcx), a newborn immature neuron marker (Gleeson et al.,
1999; Fig. S1, Supporting information). In 3-month-old mice, Dcx-
positive newborn immature neurons distributed mainly in the inner one-
third of the granule cell layer (GCL) of the hippocampal dentate gyrus
(HDG) (Fig. 1A). In comparison with 3-month-old adult mice, we
observed an obvious reduction in newborn immature neuron number
with very few Dcx-positive cells sporadically located in the inner one-
third of GCL in the HDG of 12-month-old mice (Fig. 1B). At higher
magnification, we can clearly see each individual Dcx-positive cell located
at the inner granule cell layer (Fig. 1C,D). There were 11 098  2841
newborn immature neurons per HDG in the 3-month-old mice, but this
number reduced to 341  54 in the 12-month-old mice, indicating a
dramatic reduction in the number of newborn immature neurons in the
aged animal (P = 0.022, Fig. 1E).
At higher magnification, dendrites of immature neurons were also
clearly revealed growing toward molecular layer (Fig. 1C,D). Dcx-positive
cells in the 12-month-old mice exhibited decreased dendritic morphol-
ogy compared with 3-month-old mice. By dendrite reconstruction, we
quantitatively assessed dendritic morphology of newborn immature
neurons in the HDG of adult (n = 3, 46 neurons in total) and aged mice
(n = 4, 91 neurons in total) (Fig. 1F,G). In 3-month-old mice, newborn
neurons typically have 4.1  0.4 dendritic branches with a total length
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Fig. 1 Aging decreases immature neuron
number and impairs dendritic morphology
development in newborn immature
neurons in the hippocampus in aged mice.
(A, B) Immunostaining with antibody
against doublecortin (Dcx, red) shows
immature neurons in the hippocampal
dentate gyrus (HDG) of 3-month-old (A)
and 12-month-old mice (B). 40,6-diamidino-
2-phenylindole (DAPI, blue) staining shows
the structure of HDG. (C-D) Image of higher
magnification shows structure of Dcx-
positive immature neurons in A and B
(indicated by white boxes). (E)
Quantification of Dcx-positive newborn
immature neuron number in the HDG of
3-month-old (n = 3) and 12-month-old
(n = 4) mice. (F, G) Reconstruction of
dendrites from Dcx-positive newborn
immature neurons in the HDG of 3-month-
old (F) and 12-month-old (G) mice. (H, I)
Quantification of average dendritic branch
number (H), and total dendritic length (I) of
Dcx-positive immature neurons in the HDG
of 3-month-old and 12-month-old mice.
(*P < 0.05, **P < 0.01).
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of 297.0  65.4 lm (Fig. 1H,I). In the 12-month-old cohort, newborn
neuron dendritic number dramatically fell by 58% to 1.7  0.2 per
neuron (P = 0.004, Fig. 1H), while total dendritic length was signif-
icantly decreased to 70.6  18.2 lm per neuron (P = 0.022, Fig. 1I),
representing a 76% drop. Collectively, we observed dramatically
decreased newborn immature neuron number and impaired dendritic
morphology in the newborn neurons in the HDG of the aged mice,
which recapitulates previous report in aged rats (Rao et al., 2006).
The effect of DHF on newborn neuron survival in aged mice
So far, no effective drug exists for delaying or preventing age-related
cognitive decline. Developing approaches aimed at promoting neuroge-
nesis and/or dendritic morphology is necessary. One potential target for
therapeutic interventions is brain-derived neurotrophic factor (BDNF),
known to promote neuronal growth and survival and decrease in aging
(Binder & Scharfman, 2004; Budni et al., 2015). However, the poor
permeability through the blood–brain barrier and the potential immune
reactivity largely limit direct application of BDNF. A small molecule, DHF,
with high affinity for the BDNF receptor TrkB (Jang et al., 2010), is thus
applied to activate BDNF signaling pathway in some circumstances (Choi
et al., 2010; Liu et al., 2010; Andero et al., 2012; Zeng et al., 2012;
Marongiu et al., 2013; Zhang et al., 2014). Previous studies in our group
have proven the effects of DHF on BDNF receptor TrkB (Chen et al.,
2015), and the beneficial roles of DHF on newborn immature neuron
survival and dendritic morphology development in the HDG after
traumatic brain injury (Zhao et al., 2015). Therefore, we assessed
whether activation of BDNF signaling by applying DHF could also rescue
the decline in neurogenesis and deficits of dendritic morphology caused
by aging.
First, we sought to determine whether DHF promotes newborn
neuron survival in the HDG of aged mice. Twelve-month-old mice
received injections of DHF (5 mg kg1 dissolved in dimethyl sulfoxide
[DMSO], n = 4), 70% DMSO (n = 4), or phosphate-buffered saline
solution (PBS, n = 4) once daily for 2 weeks. All mice were sacrificed
24 h after the last injection, and brains were removed (Fig. 2A) for
assessing the number of immature neurons and dendrite morphologies.
Immunostaining of every one out of six brain sections was performed
using the doublecortin (Dcx) antibody to detect newborn neurons in the
hippocampus. In DMSO vehicle-treated mice, we observed very few Dcx-
positive cells compared with PBS-treated aged mice (Figs 1B and 2B,C).
After DHF treatment, the number of Dcx-positive cells did not show
dramatic alteration (Fig. 2D). At higher magnification, we can count
each single Dcx-positive cell (Fig. 2E–G). The average number of Dcx-
positive cells per HDG in the DHF-treated group was 330  111,
compared with 293  191 in the DMSO vehicle group, and 341  54 in
the PBS control group (Fig. 2H). No statistic difference was detected
among all three treated groups. Therefore, DHF treatment for 2 weeks
did not increase newborn immature neuron survival in the HDG in aged
mice. Our previous study showed that treatment with DHF for 2 weeks
at the same dose increased the number of adult-born immature neurons
in the hippocampus of young adult animals (Zhao et al., 2015). Thus,
longer treatment with DHF may be required to significantly promote
immature neuron survival in the aging animal.
DHF improved dendritic morphology in aged mice
Although DHF did not increase newborn neuron survival in aged mice,
microscopy revealed a change in their dendritic morphology (Figs 2E–G
and 3A–C). Images at 409 magnification were taken of each
hippocampal Dcx-positive cell using the Zeiss microscopy system. The
cell bodies and dendrites were then traced and reconstructed using
Neurolucida software (Fig. 3D) and analyzed with NeuroExplorer
(Fig. 3E–H). We found the average number of dendritic branch per
neuron slightly increased from 1.7  0.2 in the PBS group (n = 4, 91
neurons in total) and 1.6  0.04 in the DMSO vehicle group (n = 4, 94
neurons in total) to 2.1  0.4 in the DHF treatment group (n = 4, 109
neurons in total), but the difference was not significant (Fig. 3E).
However, the average dendritic length per branch was dramatically
increased from 32.1  3.4 lm in PBS and 38.3  5.5 lm in DMSO
groups to 47.6  3.4 lm after DHF treatment (Fig. 3F). As a result, total
dendritic length per neuron was dramatically increased from
70.6  18.2 lm in the PBS solution group and 67.0  9.8 lm in the
DMSO vehicle group to 110.3  23.7 lm after DHF treatment (Fig. 3G).
By further splitting newborn immature neurons into different categories
according to their total dendritic length, we discovered in PBS and DMSO
control groups, newborn immature neurons primarily develop very short
dendrites within 50 lm to their soma in total (67.8  8.8% in PBS mice,
61.4  2.4% in DMSO mice, Fig. 3H). The percentage of newborn
neurons with short total dendritic length within 50 lm was dramatically
reduced to 45.9  5.7% in the DHF group (Fig. 3H). Consequently,
more newborn neurons in the DHF-treated mice developed relatively
long dendrites > 200 lm to their soma, accounting for 18.7  2.6% in
all the measured newborn neurons compared with only 8.4  3.3% in
the PBS group and 5.1  2.0% in the DMSO group (Fig. 3H).
Collectively, although DHF did not promote newborn immature neurons
to grow more dendritic branches, it instead improved dendritic devel-
opment by enhancing dendritic elongation shown as increased average
and total dendritic length in aged mice, as well as shifting the
percentage of newborn immature neurons toward the category with
longer total dendrites at a population level.
Discussion
As the aged population grows rapidly, age-dependent cognitive decline
will become an increasing problem for our society (Ortman et al.,
2014). However, the molecular mechanism of this decline is largely
unknown, hindering development of a therapy to delay or prevent it.
Neuroplasticity, represented by hippocampal neurogenesis and synaptic
plasticity, which are important events for learning and memory
capacity, was reported to be compromised as age advances in rodents
and humans (Burke & Barnes, 2006; Rao et al., 2006). In the present
study, we used 12-month-old mice and observed some of the
characteristics previously seen in aging subjects, most notably
decreased newborn immature neuron number and impaired dendritic
morphology in those newborn neurons, compared with 3-month-old
young adult cohort (Fig. 1). These observations represent deficits in
neurogenesis and synaptic plasticity in the aging group. Approaches
aimed at neurogenesis and/or synaptic plasticity enhancement might be
potential therapeutic targets.
So far, no effective treatment is available to enhance neurogenesis or
synaptic plasticity for aged subjects. Exercise has been shown to be
beneficial to overall general health (Kempermann et al., 1997, 1998;
Kempermann & Gage, 1999; van Praag et al., 1999a,b; Cotman &
Berchtold, 2002). The running mice perform much better than sedentary
mice in learning tasks, for example, spatial learning. The more complex
the tasks are, the better the exercising mice perform (van Praag et al.,
1999a, 2000). It has been shown that physical exercise moderately
enhances neurogenesis in the adult hippocampus (van Praag et al.,
1999b, 2005; Kempermann et al., 2000) and improves functional
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performance following TBI (Wagner et al., 2002; Kline et al., 2007;
Hoffman et al., 2008), whereas brain-derived neurotrophic factor
(BDNF) has been found to enhance the survival and dendritic growth
of newborn neurons in the hippocampus (Tolwani et al., 2002; Wang
et al., 2015) and may be potentially beneficial for neurogenesis and/or
synaptic plasticity in aged subjects as well. A small-molecule BDNF
receptor agonist, DHF (Jang et al., 2010), surpasses BDNF due to its
permeability through the blood–brain barrier and low immune reactivity
when alternatively applied to activate BDNF signaling. In previous
studies, we have proven the beneficial roles of DHF pre- or post-
treatment in the case of traumatic brain injury by activating the BDNF
receptor TrkB, promoting newborn neuron survival, and enhancing
newborn neuron dendritic development (Chen et al., 2015; Zhao et al.,
2015). In the present study, we proposed that the beneficial roles of DHF
would also improve neurogenesis and/or synaptic plasticity in the case of
aging. We applied DHF for 2 weeks, and surprisingly, it did not
significantly increase newborn neuron survival in aged mice (Fig. 2).
However, we did discover extensive dendritic morphological changes
between the control and treatment groups. Our data suggested that by
daily injection of DHF for 2 weeks, although dendritic branch number of
newborn neurons was not significantly altered, the average dendritic
length of newborn neurons was dramatically increased by 48%
compared with the PBS group and by 24% compared with the DMSO
vehicle group (Fig. 3F). Similarly, total dendritic length of newborn
neurons was dramatically increased by 53% compared with the PBS
group and by 64% compared with the DMSO vehicle group (Fig. 3G).
Additionally, we observed a shift of the constituent ratio of newborn
neurons toward the category with longer dendrites, shown as a 2.2-fold
increase in the proportion of neurons with total dendrites longer than
200 lm (Fig. 3H).
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Fig. 2 DHF treatment did not significantly
increase newborn immature neuron
number in the hippocampus in aged mice.
(A) Schematic shows experimental strategy.
(B–D) Immunostaining with doublecortin
(Dcx, red) shows immature neurons in the
hippocampal dentate gyrus (HDG) of 12-
month-old mice that received phosphate-
buffered saline (PBS; n = 4, B), dimethyl
sulfoxide (DMSO; n = 4, C), and 7, 8-
dihydroxyflavone (DHF; n = 4, D)
treatments. 40,6-diamidino-2-phenylindole
(DAPI, blue) staining shows the structure of
HDG. (E-G) Images of higher magnification
from B-D (indicated by white boxes) show
individual Dcx-positive immature neurons in
the HDG of 12-month-old mice received
PBS (E), DMSO (F), and DHF (G) treatments.
(H) Quantification of Dcx-positive immature
neuron number in the HDG of 12-month-
old mice received PBS, DMSO, and DHF
treatments.
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Similarly, Zhang et al. (2014) discovered that exposure to 500 nM DHF
for 3 days increased total dendrite length and number in cultured
neurons, and Zeng et al. (2012) found that spine density and number
were markedly increased in 22-month-old rats treated with DHF daily for
34 days. In the 30-month-old rats that received an identical treatment,
DHF restored spine density but not dendrite number (Zeng et al., 2012).
Although differences exist among studies, possibly resulting from varying
treatment protocols and ages of animals, overall improvements in
dendritic morphology were observed from various perspectives. Den-
drites form synapses with axons from surrounding neurons and transmit
information to the neuron’s cell body. A decline in the length and
number of dendrites available to receive and transmit information
impairs neuronal signaling in aged subjects, while DHF improved
dendritic length, which serves as a foundation for potential gain of
synapses and restoration of signaling transmission.
BDNF has been shown to control the shape and number of
dendritic spines, thus influencing the development of synaptic circuits
particularly in the hippocampus (Ji et al., 2005; Cohen-Cory et al.,
2010). Our previous study directly demonstrated that BDNF knockout
impaired synapses formation in postnatal granule cells in hippocampal
dentate gyrus (Gao et al., 2009). Here, we showed that the total
length of dendrites of each newborn neuron dramatically reduced
with aging.
The total length of dendrites in each neuron reduced to 23.7% from
a mouse aged 3 to 12 months. DHF treatment in the present study
significantly increased both the average and the total length of dendrites
in each newborn neuron in the aged mouse. However, compared with
the 3-month-old young adult cohort, the dendrites in aging mice after
DHF treatment were still much shorter, representing only 37% of the
adult level at the age of 3 months old. Additionally, we did not evaluate
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Fig. 3 DHF treatment improved dendritic
morphology development in newborn
immature neurons in the hippocampus in
aged mice. (A–C) Immunostaining with
antibody against doublecortin (Dcx, red)
shows structure of individual immature
neurons in the hippocampal dentate gyrus
(HDG) of 12-month-old mice received
phosphate-buffered saline (PBS; n = 4, B),
dimethyl sulfoxide (DMSO; n = 4, C), and
7, 8-dihydroxyflavone (DHF; n = 4, D)
treatments. 40,6-diamidino-2-phenylindole
(DAPI, blue) staining shows the structure of
granule cell layer. (D) Reconstruction of
dendrites from Dcx-positive immature
neurons in the HDG of 12-month-old mice
received PBS, DMSO, and DHF treatments.
(E–G) Quantifications of average dendritic
branch number (E), average dendritic
length (F), and total dendritic length (G) of
Dcx-positive immature neurons in the HDG
of 12-month-old mice received PBS, DMSO,
and DHF treatments. (H) Constituent ratio
of Dcx-positive immature neurons with
total dendritic length in different categories
in the HDG of 12-month-old mice received
PBS, DMSO, and DHF treatments.
(*P < 0.05, **P < 0.01, ***P < 0.001).
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dendritic spine and synapse formation on the elongated dendrites.
Although longer dendrites provide larger surface area and thus may
allow neurons to form more synapses with upstream neurons, ampli-
fication of dendritic length in hippocampal granule neurons does not
necessarily guarantee synaptogenesis and consequent improvement in
cognition in aged mice. Further investigations are needed to explore the
effect of DHF on mature neuron functions and behavioral performances
in aged animals.
BDNF expression level has been reported to be decreased in the
hippocampus in aged rats (Calabrese et al., 2013) and thus was
considered a potential reason for age-dependent neurogenesis and
dendritic impairments. Aimed at this issue, we treated 12-month-old
mice with DHF to activate BDNF signaling and observed improved
dendritic morphology in the aged mice, while the molecular mecha-
nism is still largely unknown. Numerous studies have also highlighted
the ability of DHF to influence dendrite synapse density through TrkB
upregulation (Luine & Frankfurt, 2013; Castello et al., 2014); however,
little research has been performed on the downstream effects of DHF
on signaling pathway regulation and/or gene expression level. Several
ubiquitous intracellular signaling pathways have been reported to be
involved in BDNF-TrkB system activation, including PI3K/Akt, Ras/MEK/
ERK, and PLCc/IP3 signaling (Chao, 2003; Duman & Voleti, 2012;
Russo & Nestler, 2013). Downstream effects may consist of mTOR
activation and following global protein synthesis, as well as CREB
phosphorylation by ERK- or calcium-activated CAMK and subsequent
CREB nuclear translocation-activated gene expression (Fig. 4). As TrkB
agonist imitating BDNF actions, DHF potentially benefits dendritic
morphology development by modulating these signaling pathways in
aged subjects and thus may potentially improve synaptic transmission
and cognitive outcomes in aged subjects. Further investigations are
needed to elucidate the mechanisms and to facilitate therapeutic
applications of DHF to improve cognitive functions in the aged
population.
Experimental procedures
Animal care
Male C57 BL/6 mice (Jackson Laboratories) were group-housed and kept
in a 12-h/12-h light/dark cycle with free to access to food and water at
all times. The animals were used in experiments at ages of 3 and
12 months. All procedures were performed under protocols approved by
Indiana University’s Animal Care and Use Committee.
DHF treatment
Mice at the age of 12 months received either DHF (5 mg kg1 as applied
in previous study (Zhao et al., 2015), dissolved in dimethyl sulfoxide
[DMSO], n = 4), 70% DMSO (n = 4), or phosphate-buffered solution
(PBS, 50 mg kg1, n = 4, intraperitoneal [i.p.]) injections once a day for
2 weeks. Twenty-four hours after the last injection, the mice were
sacrificed for quantifying newborn neurons and assessing newborn
neuron dendrite morphology (Fig. 2A).
Tissue processing
Animals were deeply anesthetized with 2.5% avertin and then were
perfused transcardially with cold 0.9% saline, followed by a cold fixative
containing 4% paraformaldehyde (PFA) in PBS. The brains were
removed, postfixed in PFA overnight, and cryoprotected with 30%
sucrose for 48 h. Serial coronal sections (30 lm thick) were cut using a
cryostat (Leica, CM1900, Wetzlar, Germany) and stored at 20 °C. The
sections were then processed for immunohistochemical analysis.
Immunohistochemistry
Series of every sixth section (180 lm apart) through each hippocampus
were processed with standard floating sections immunostaining. Each
section was washed with PBS three times for 30 min. The sections were
blocked in PBS containing 5% normal goat serum, 0.1% bovine serum
albumin (BSA), and 0.1% Triton x-100. Antidoublecortin (Dcx) primary
antibody (1:1000, guinea pig; EMD Millipore, Darmstadt, Germany) was
applied overnight at 4 °C. Then, goat anti-guinea pig secondary
antibody from Jackson Immunoresearch was applied at 1:1000 dilution.
Cell counting
Immunohistochemistry was performed simultaneously on sections to
detect the Dcx-positive cells. Series of every sixth section (30 lm thick,
180 lm apart) through each hippocampus were processed. The cell
number was determined through a blinded quantitative histological
analysis under a profile count protocol as described previously (Gao &
Chen, 2013). Briefly, every single Dcx-positive cell was counted
throughout the granular cell layer (GCL) in the 30-lm section in
multiplanes.
Fig. 4 Potential mechanisms involved in DHF-improved dendritic morphology
development. Intracellular signaling pathways that have been reported to be
involved in BDNF-TrkB system activation. Downstream effects may consist of mTOR
activation and following global protein synthesis, as well as CREB phosphorylation
by ERK- or calcium-activated CAMK and subsequent CREB nuclear translocation-
activated gene expression. PI3K: Phosphoinositide 3-kinase; Akt: Protein kinase B;
mTOR: Mammalian target of rapamycin; CREB: cAMP response element-binding
protein; PLCc: Phospholipase C c; IP3: Inositol triphosphate; CAMK: Calcium-/
calmodulin-dependent protein kinase.
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Microscopy
The sections were analyzed using an inverted microscopy system (Zeiss
Axiovert 200M, Oberkochen, Germany) combined with ApoTome and
interfaced with a digital camera (Zeiss AxioCam MRc5) controlled by a
computer. Images were captured using ApoTome in conjunction with
AXIOVISION v4.8 software (Zeiss AxioVision, v4.8) and then assembled and
labeled in PHOTOSHOP 7.0 (Adobe Systems, San Jose, CA).
Dendrite tracing and analysis
409 images of each individual Dcx-positive cell, which has dendritic
structure, were captured and used to trace neuron cell bodies and
dendrites using the NEUROLUCIDA software (MBF Bioscience, Williston, VT,
USA). The neuron tracings were then analyzed on NEUROEXPLORER software
(Next Technologies, Madison, AL, USA). In 3-month-old adult mice, 46
neurons in total (n = 3) were analyzed. In 12-month-old mice, 91
neurons in total (n = 4), 94 neurons in total (n = 4), and 109 neurons in
total (n = 4) were assessed in PBS, DMSO, and DHF groups, respectively.
Statistical analysis
The collected data were expressed as average  standard deviation. Data
of comparison on newborn immature neuron number, average dendritic
number, and total dendritic length in 3-month-old and12-month-oldmice
were analyzed using Student’s t-test (Fig. 1E,H,I). Results on newborn
immature neuron number, average dendritic number, average dendritic
length, and total dendritic length after PBS, DMSO, and DHF treatments in
12-month-old mice (Figs 2H and 3E–G) were analyzed by one-way
analysis of variance (ANOVA) followed by Fisher’s least significant difference
(LSD) as post hoc test. Data of constituent ratio of newborn immature
neuron total dendritic length in different categories in 12-month-old mice
that received PBS, DMSO, and DHF treatments (Fig. 3H) were analyzed via
two-way ANOVA followed by one-way ANOVA with LSD as post hoc test.
Statistical analysis were performed using SPSS software (IBM Cooperation,
Armonk, NY) with significance set at P < 0.05.
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Fig. S1 Large majority of Dcx-positive cells in the aged hippocampus are
postmitotic immature neurons.
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